Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometriosis × relugolix × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 29 Prostate Adenocarcinoma 2 Adenocarcinoma 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Endometriosis 1

Interventions

relugolix 1 Rocuronium 1 Immunonutrition Diet 1 Fluconazole 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093390 2016-06-06

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

Millennium Pharmaceuticals, Inc.

Phase 1 Completed

40 enrolled 23 charts

Endometriosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡